Analysis-Healthcare companies counter investor worries over Wegovy effect
© Reuters. FILE PHOTO: A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo
By contrast, the iShares U.S. Medical Devices exchange-traded fund has lost more than 22% in the last three months. Margaret Kaczor Andrew, a William Blair analyst covering medical technology companies, says she does not expect a meaningful effect on technologies like glucose monitors, which help manage diabetes. She pointed to the emergence of other drug classes like statins that had reduced cardiovascular disease but not decreased the need for heart devices.
"We expect that many of them will not stay on the drug for longer than a year or two, and at that time, will consider bariatric surgery," Myriam Curet, chief medical officer at Intuitive Surgical , said on the company's Oct. 19 earnings call."Overall, we'll see an increased interest in bariatric surgery, but that will get delayed in the short term."
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Norwich healthcare should be investigated by NHS, say councillorsCommissioners are trying to keep health services running after a contractor said it would pull out.
Weiterlesen »
How Walgreens, CVS and Rite Aid tried to take over healthcare — and failedThe pharmacy chains have discovered that taking a larger role in the healthcare system than simply dispensing prescriptions and selling over-the-counter notions is more complicated and costlier than they expected.
Weiterlesen »
Web3 healthcare information platform Rymedi raises $9 million in Series A fundingRW3 Ventures and White Star Capital co-led the round, with additional participation from Blockchange Ventures and Avalanche’s Blizzard Fund.
Weiterlesen »
Nearly 500 jobs lost following healthcare company closing in OpelikaBaxter is an American Multinational Healthcare company. They primarily focus on products to treat kidney disease, like renal filters for dialysis. Formally known as Gambro, they chose to settle in Opelika back in 2005, investing $165 million into their facility.
Weiterlesen »
Fat Joe, Method Man, French Montana, Rap Legends Advocate For HealthcareFat Joe and French Montana have long been advocates for fair and just pricing in the healthcare system ... and for their latest PSA, they've brought backup!!!
Weiterlesen »
CHG Healthcare: A top workplace for growth, inclusion, and purposeCHG Healthcare isn’t just known as a top healthcare staffing company; it’s also known for its people-first culture that empowers employees to build rewarding careers and bring their whole selves to work.
Weiterlesen »